Lactiga featured in the Toronto Star Lactiga’s R&D on milk antibodies against COVID-19 was featured in the Toronto Star, one of Canada’s largest newspapers:...
Lactiga secures its American patent Lactiga received notification of issuance of its US patent, completing the first phase of its intellectual property...
Lactiga wins the Canada India foundation’s healthcare innovation award. Lactiga was one of only 6 winners of the Canada India Foundation’s Healthcare Innovation Award in recognition of our application of biotechnology to the COVID-19 pandemic. This cash award...
Lactiga selected for the RESI Innovator’s Pitch Challenge Lactiga is 1 of 6 Featured startups at the Redefining Early Stage Investments virtual conference from November 17-19th. We were granted a dedicated web presence and a spotlighted pitch...
Original Post PRINCETON, N.J.--(BUSINESS WIRE)--Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001, announced today a collaboration agreement ...
